FDA Inspection
Turbare ManufacturingTurbare Manufacturing – FDA Inspection, Jan 24, 2025
Record Details
This FDA Inspection record concerns Turbare Manufacturing, with an inspection on January 24, 2025, issued by the Dallas District Office, covering human drugs.
View Company Profile
ID · 0d7e9368-37a2-4e5c-8858-61dcd15fa8ab
Inspection Facts
Official Action Indicated (OAI)
Significant objectionable conditions were found and regulatory or administrative action is recommended.
- Inspection number
- 1259059
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
- Outcome
- Form 483 issued
FDA Citations
8- 21 CFR 211.165(d)Acceptance criteria for sampling & testing
- 21 CFR 211.100(a)Absence of Written Procedures
- 21 CFR 211.194(a)(8)Second person sign off
- 21 CFR 211.113(b)Procedures for sterile drug products
- 21 CFR 211.113(b)Validation lacking for sterile drug products
- 21 CFR 211.110(a)Control procedures to monitor and validate performance
- 21 CFR 211.25(a)Training , Education , Experience overall
- 21 CFR 211.192Investigations of discrepancies, failures
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Turbare Manufacturing
1| Date | Classification | Office | Project area |
|---|---|---|---|
| May 7, 2026 | Not classified | Dallas District Office | Drug Quality Assurance |
Other documents for Turbare Manufacturing
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.